ReviewCureus2026
Clinical Significance and Long-Term Prognosis of Appendiceal Orifice Inflammation in Ulcerative Colitis: A Systematic Review.
Review in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Appendiceal orifice inflammation (AOI), also described as a peri-appendiceal red patch or cecal patch, is a recognized skip lesion in ulcerative colitis (UC), although its clinical significance and long-term prognostic implications remain uncertain. This systematic review with narrative synthesis, conducted in accordance with PRISMA 2020 guidelines, evaluated the available evidence from comparative observational studies of UC patients with and without AOI. Nine comparative cohort studies published between 2002 and 2022 were included, with sample sizes ranging from 39 to 376 patients. Across the included studies, AOI was most frequently observed in patients with distal or limited UC. Some cohorts reported associations with higher baseline inflammatory activity or lower rates of complete endoscopic remission, while others did not demonstrate significant differences in short-term treatment response. Proximal disease extension emerged as the most consistently reported long-term association, particularly in patients with initial proctitis; however, this finding did not consistently translate into worse overall clinical outcomes. Most studies did not show a clear increase in major adverse outcomes such as hospitalization or colectomy. Findings regarding treatment escalation were variable, with some studies suggesting an increased likelihood of therapy intensification, whereas others found no independent prognostic impact. Overall, AOI appears to be a clinically relevant but heterogeneous finding in UC that does not consistently function as an independent marker of poor long-term prognosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.